Sidley Austin LLP advised Tempest Therapeutics, Inc. on the deal.Tempest Therapeutics, Inc., a privately-held, clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and…
Tempest Therapeutics’ Merger With Millendo Therapeutics
